Nuclear AREG affects a low‐proliferative phenotype and contributes to drug resistance of melanoma
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Cancer"
DOI: 10.1002/ijc.34254
Abstract: AMPHIREGULIN (AREG) is a multifaceted molecule, which acts not only as an extracellular ligand for EGF receptor (EGFR), but also as an intracellular signaling molecule. It remains elusive, however, whether AREG has a tumor suppressive… read more here.
Keywords: areg affects; areg; resistance melanoma; nuclear areg ... See more keywords